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Promyelocytic leukemia HL-60 cells promoted by PMA to differentiate along the
monocyte pathway adhere to tissue culture plates. To explore the regulation of
adhesion molecules in cells promoted to differentiate, the expression and secre-
tion of osteopontin (OPN) and expression of associated cell surface receptors,
CD44 and integrin subunits av , b3 , b1 , were examined. Results were as follows:
1) PMA induced OPN mRNA and OPN secretion into media; 2) untreated cells
expressed b1 and CD44 mRNA, and PMA induced av and b3 mRNA and increased
b1 and CD44 mRNA expression; 3) PMA increased levels of av , b3 , b1 and CD44
protein on the cell surface; and 4) retinoic acid, which promotes granulocytic
differentiation of HL-60 cells, did not affect OPN, av , b3 , b1 , or CD44 mRNA or
protein expression. These data suggest that induction of OPN and associated
receptors may play a role during monocytic differentiation of HL-60 cells.
J. Cell. Physiol. 175:229–237, 1998. q 1998 Wiley-Liss, Inc.
Osteopontin (OPN), an adhesion molecule, also More specifically, there is substantial evidence that
OPN plays a critical role in regulating macrophage ac-known as SPP-1 (secreted phosphoprotein-1), 44 kDa,
tivity at sites of wound healing (Miyazaki et al., 1990;bone sialoprotein I, and the cytokine Eta-1 (early T
Hirota et al., 1993; Giachelli et al., 1995; Singh et al.,lymphocyte activation), is a phosphorylated glycopro-
1990), which includes the presence of high levels oftein mediating cell attachment and cell migration, at
OPN in macrophages associated with inflammationleast in vitro, via an arginine-glycine-aspartic acid
(Miyazaki et al., 1990; Singh et al., 1990). This has led(RGD) sequence (for review see Butler et al., 1996;
researchers to hypothesize that OPN has an importantDenhardt et al., 1995). OPN has been identified in sev-
function at such sites, including a role in controllingeral tissues, cells, and biological fluids, including bone,
attachment, migration, and phagocytic activity of mac-kidney, placenta, smooth muscle, neurosensory cells,
rophages in an autocrine fashion, as well as promotingepithelial cells, blood, milk, urine, activated T lympho-
migration of fibroblasts, muscle cells, and endothelialcytes, and macrophages. In addition, the process of
cells to the wound-healing site. However, the precisetumorigenesis and metastasis is correlated with induc-
mechanisms by which OPN affects macrophage behav-tion of OPN expression (Gardner et al., 1994; Behrend
ior have not been elucidated. Furthermore, specific re-et al., 1994). In spite of extensive research on this mole-
ceptors on cell surfaces of macrophages interactingcule, the exact function of OPN remains unknown and
with OPN and subsequently eliciting a variety of cellmost likely is tissue- specific. Broad functions hypothe-
signaling activities have not been conclusively estab-sized for OPN include 1) to facilitate attachment/migra-
lished. Putative receptors for OPN that may be associ-tion of cells to specific sites (e.g. site of bone develop-
ated with influencing intracellular signaling pathwaysment, bone remodeling, inflammation, and tissue re-
pair) (Dodds et al., 1995; Patarca et al., 1993; Reinholt
et al., 1990; Ek-Rylander et al., 1994), 2) to modulate Contract grant sponsor: National Cancer Institute of Canada;
Contact grant number: 6015; Contact grant sponsor: NIDR/NIH;crystal formation in mineralized tissues and other bio-
Contact grant number: DE10337.logical fluids such as urine (McKee and Nanci, 1995a,b;
Hoyer et al., 1995; Hunter et al., 1994; Boskey et al., *Correspondence to: Martha J. Somerman, Department of
Periodontics/Prevention/Geriatrics, University of Michigan,1993), and 3) to play a protective role by inhibiting
1011 N. University Ave., Ann Arbor, MI 48109-1078. E-mail:apoptotic events and/or controlling cell function at sites
somerman@umich.eduof inflammation (Patarca et al., 1993; Denhardt and
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include avb3 , avb1 , avb5 , and CD44 (Giachelli et al., Amersham (Arlington, IL). Trizol total RNA isolation
kit was from GIBCO Life Technologies, Inc., and1995; D’Errico et al., 1995; Teitelbaum et al., 1995;
Helfrich et al., 1992; Liaw et al., 1995; Horton et al., Duralon-UV membranes and random primer kit,
Prime-itR-II, were purchased from Stratagene (La1995; Weber et al., 1996; Somerman et al., 1995). Im-
portantly, RGD containing proteins (Parker et al., Jolla, CA). Monoclonal anti-human integrin b1 (MAb
Ascites, clone P4C10) and anti-human integrin av (MAb1988; Gresham et al., 1989) and associated receptors
(e.g., avb3 [Savill et al., 1990; Fadok et al., 1992]) have Ascites, clone VN147) were purchased from GIBCO.
Monoclonal anti-human CD61 (b3 ; MAb Ascites, clonebeen implicated as having a role in stimulating phago-
cytic activity in cells. An understanding of the mecha- RUU-PL 7F12), mouse IgG1 and IgG2a monoclonal con-
trol, and FITC-labeled goat anti-mouse IgG were pur-nisms regulating expression of OPN and associated re-
ceptors in macrophages is a necessary first step for chased from Becton Dickinson (San Jose, CA). Mono-
clonal anti-human CD44 (purified, clone A3D3), whichachieving improved methods for inducing maintenance
and repair of tissues. recognizes all CD44 isoforms, was purchased from
Sigma.As an initial approach, we have focused on determin-
ing the timed expression of OPN and its putative cell
cDNA probessurface receptors during differentiation of HL-60 cells.
HL-60 cells, a human promyelocytic leukemic cell line, The cDNA probes used for these studies included a
can be induced to differentiate along both the mono- human OPN cDNA, a gift from Dr. Marion Young
cytic/macrophage or granulocyte pathway. Without (Young et al., 1990) (NIDR/NIH), human av , b1 , and b3stimulation, HL-60 cells maintain a rounded morphol- placenta cDNA, kindly provided by Dr. Scott Argraves
ogy and grow in suspension, but, when promoted by (Argraves et al., 1987), CD44 (American Type Culture
phorbol esters to differentiate along the monocyte/mac- Collection (ATCC), Rockville, MD), a cDNA for chicken
rophage pathway, they become adherent and spread glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
on tissue culture plates (Somerman et al., 1995). In (Dugaiczyk et al., 1983), and a cDNA for 18S rRNA
contrast, HL-60 cells induced to differentiate along the (Kenneth Zaret, Brown University, Providence, RI).
granulocyte pathway by retinoic acid do not adhere or
spread on tissue culture-treated dishes. The ability of Cell culture
cells differentiating along the monocyte/macrophage
HL-60 cells, obtained from American Type Culturepathway to adhere, coupled with several reports sug-
Collection, were cultured in RPMI 1640 media supple-gesting a role for the adhesion molecule osteopontin in
mented with 10% fetal calf serum, 2 mM L-glutamine,the regulation of macrophage and osteoclast activities
100 IU/ml penicillin, and 100 mg/ml streptomycin.(for review see Butler et al., 1996; Denhardt et al.,
Cells were used between passage 20 and 45. For experi-1995; Giachelli et al., 1995), prompted us to determine
ments, cells were seeded at a 2 1 105 cells/ml andwhether or not HL-60 cells expressed OPN. The results
treated with vehicle control (ethanol), PMA at doses ofof these initial studies demonstrated that mRNA levels
0.15 nM, 0.5 nM, or 1.5 nM, or retinoic acid (RA) atfor OPN increased in HL-60 cells exposed to phorbol
doses of 10 nM, 100 nM, or 1000 nM. All experimentsesters (Somerman et al., 1995). We now extend these
were replicated at least three times. Dose selection wasstudies to more carefully examine the time course of
based on previous studies in our laboratory demonstra-OPN expression and correlation of this expression with
ting induction of differentiation by PMA along thethat of its putative receptors. These studies are of sig-
monocyte pathway or by RA along the granulocytenificance since adhesion molecules and their associated
pathway, as measured by function assays (nonspecificreceptors have been implicated as having a role in regu-
esterase (NSE) activity and nitroblue tetrazoliumlating cell differentiation, yet the precise role of these
(NBT) dye reduction assay), cell attachment (PMAmolecules during cell differentiation warrants further
only), and changes in cell morphology (for review seeclarification (for review see Hynes, 1992; Lin and Bis-
Tsiftsoglou and Robinson, 1992). Assays, includingsell, 1993; Schwartz, 1993; Collins, 1987).
NBT, NSE, and morphological changes, were run rou-More recently, Andersson and Johansson (1996)
tinely to assure that cells were functionally similar.demonstrated that the increased expression of OPN
mRNA in HL-60 cells is associated with increased ad- Northern blot analysishesion and that the increased adhesion was dependent
in part upon the presence of avb3 . It was therefore of Cells were harvested at specified times from 6 h to
72 h and total RNA isolated using Trizol reagent. Equalinterest to demonstrate that OPN mRNA expression is
mirrored by OPN protein secretion and to investigate amounts of RNA (20 mg/lane) were denatured and elec-
trophoresed on 1.2% agarose-6% formaldehyde gels,whether the expression of receptors associated with
OPN is coordinately controlled in phorbol ester-stimu- transferred to a Duralon-UV membrane, and immobi-
lized by UV cross-linking (Stratalinker; Stratagene).lated HL-60 cells.
Membranes were hybridized with the indicated a-32P
MATERIALS AND METHODS cDNA probes labeled using a Prime-itR-II random
Reagents primer kit, washed under standard conditions, and ex-
posed to X-ray film (Kodak X-Omat AR, Rochester, NY)RPMI 1640 media and fetal calf serum were pur-
chased from GIBCO Life Technologies, Inc. (Rockville, with intensifying screens at 0707C. GAPDH and 18S
marker were used to account for any differences in load-MD). Phorbol 12-myristate 13-acetate (PMA) and reti-
noic acid were from Sigma (St. Louis, MO). Radiola- ing concentrations. All experiments were repeated at
least three times.beled (a-32P)dCTP (3,000 Ci/mmol) was purchased from
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ELISA
A ‘‘capture’’ ELISA method, developed by Bautista et
al. (1996), was used to measure levels of OPN in media
from HL-60 cells exposed to PMA. For this assay, a
combination of a high affinity mouse monoclonal anti-
body, mAb53 (Bautista et al., 1994), for the capture
step, and a rabbit polyclonal antiserum, for amplifica-
tion, both raised against a recombinant glutathione-S-
transferase-human OPN fusion protein (GST-hOPN),
were used (Xuan et al., 1994).
Briefly, immunoassay plates (Life Technologies, Bur-
lington, Ontario, Canada) were prepared by coating
with antibody mAb53 (100 ml/well, 10 mg/ml in 0.1 M
sodium bicarbonate, pH 9.0, 4C, 16 h) and then blocking
with 1% BSA in ST-Tween buffer [10 mM Tris, pH 8.0, Fig. 1. Time course for expression of av and OPN mRNA in HL-60
cells treated with 1.5 nM PMA or 100 nM RA. HL-60 cells were grown150 mM NaCl, and 0.05% Tween-20 (Bio-Rad, Missis-
for the indicated times in the presence of agents or vehicle control,sauga, Ontario)]. Prepared plates were then washed
0.1% ethanol, before isolation of RNA. Northern blots containing 20extensively with ST-Tween buffer. Samples of tissue
mg RNA/lane were hybridized to av and OPN cDNAs as described inculture media, obtained from cells treated as described Materials and Methods. GAPDH mRNA was used to normalize the
loading of mRNA.above, were diluted into wells containing ST-Tween
buffer with 1% BSA as diluent and incubated at 377C
for 1.5 h. Triplicates of at least threefold dilutions of
each sample (starting at 1/3) were tested. Subsequent 7.4). Labeled cells were analyzed on an Epics C Flowincubations were performed at 377C for 12 h each, except Cytometer (Coulter Electronics, Hialeah, FL) with 200
as indicated, followed by three washes in ST-Tween mW of laser power tuned to 488 nm. Log forward light
buffer. In order to amplify and detect captured OPN, scatter and log 907 light scatter were used to gate out
we sequentially incubated wells with 1) rabbit anti- debris, and fluorescence was measured at 525//025
OPN antiserum (1/1,000), 2) biotinylated goat anti-rab- nm for fluorescein. Five thousand gated events were
bit Ig antibody (1/2,000) (Life Technologies), and 3) collected for each sample and plotted on a 3 decade
streptavidin conjugated with alkaline phosphatase (1/ fluorescence scale. Files were converted to Macintosh
2,000) (Jackson Immunological Laboratories, Inc., format and plotted using CricketGraph and MacDraw.
West Grove, PA). For color development, wells were Mean channel fluorescence was calculated using
incubated with 100 ml of p-nitrophenyl phosphate (1 Coulter’s StatPak statistical analysis program and
mg/ml in 100 mM Tris, pH 9.5, 100 mM NaCl, and 5 then converted to specific linear fluorescence (Muir-
mM MgCl2), and the signal was allowed to develop at head, et al., 1983; Todd, et al., 1988).
room temperature for 4–6 min. To stop the reaction,
50 ml of 0.2 M Na2EDTA (pH 8.0) was added. A Bio- RESULTS
Effect of PMA and retinoic acid treatment onRad plate reader was used to quantify the signal. Re-
combinant GST-OPN fusion protein was used as a stan- mRNA expression for OPN and av in HL-60 cells
dard (Bautista et al., 1994, 1996). For quantification Data provided in Figure 1 demonstrate that un-
of OPN, the curve-fitting feature of SigmaPlot (Jandel treated HL-60 cells do not express OPN or av mRNA.Scientific, San Jose, CA) was used to fit data points for Cells exposed to PMA for 6 h expressed OPN but not
the protein standard into the exponential rise function. av mRNA. Increased expression for OPN was observedThe best-fit curve was used to extrapolate unknown at 24 h and maintained throughout the time period of
values when the signal was in the linear region of the this experiment (i.e., 72 h). These PMA-treated cells
standard curve. Results were expressed as mean { SD. exhibited a similar time course for adhesion, with
Data were analyzed using Student t-test for unpaired changes in morphology from rounded to more spread,
samples. Values of P õ 0.05 were considered statisti- apparent at 6 h, followed by approximately 75% of the
cally significant. cells adhering to dishes by 24 h and 90% adhesion at
48 h (data not shown). av mRNA expression was appar-Flow cytometry ent at 24 h of PMA treatment and increased thereafter
to 72 h. In contrast, cells exposed to retinoic acid didAfter 24 and 72 h of treatment, cells were harvested
using Puck’s EDTA and washed twice with phosphate- not express OPN and av mRNA, nor did they exhibit
adhesive properties at any of the time points examined,buffered saline (PBS). Cell viability was determined
by flow cytometry using ethidium monoazide. Washed from 6–72 h.
cells were resuspended in PBS at 1 1 107 cell/ml, and
Effect of PMA and retinoic acid treatment100 ml of each sample was incubated with saturating
on b1 and b3 mRNA in HL-60 cellsconcentrations of the indicated MAb (concentrations
determined by titration) or matched mouse Ig as nega- RNA levels for two integrin subunits associated with
OPN, b1 and b3 , were determined in untreated HL-60tive control for 30 min at room temperature. Samples
were then washed and incubated with fluoresceinated cells and in HL-60 cells treated with PMA or RA. As
seen in Figure 2, untreated cells express mRNA for b1goat anti-mouse secondary antibody for 30 min, washed
again, and fixed with 1% formaldehyde in PBS (pH but not for b3 . Thus, b1 is constitutively expressed, at
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Fig. 2. Time course for expression of b1 and b3 mRNA in HL-60 cells taining 20 mg RNA/lane were hybridized to b1 and b3 cDNAs as de-
treated with 1.5 nM PMA (A) or 100 nM RA (B). HL-60 cells were scribed in Materials and Methods. The loading of mRNA was normal-
grown for the indicated times in the presence of agents or vehicle ized with 18s RNA.
control, 0.1% ethanol, before isolation of RNA. Northern blots con-
the expression of message for CD44 by 24 h with a
further increase up to 72 h. RA treatment of HL-60
cells was without effect on CD44 mRNA expression.
PMA increased the secretion of OPN protein
by HL-60 cells in a time-dependent manner
To determine whether cells expressing OPN mRNA
were secreting this protein, we determined the concen-
tration of OPN in media from HL-60 cells exposed to
Fig. 3. Time course for expression of CD44 mRNA in HL-60 cells PMA at designated time points using an ELISA method
treated with 1.5 nM PMA or 100 nM RA. HL-60 cells were grown for (Bautist, et al., 1996). As shown in Figure 4, PMA (0.5
the indicated times in the presence of agents or vehicle control, 0.1% nM) induced secretion of OPN by HL-60 cells. Measur-ethanol, before isolation of RNA. Northern blots containing 20 mg
able levels of OPN in media were noted by 24 h andRNA/lane were hybridized to CD44 cDNA as described in Materials
and Methods. GAPDH mRNA was used to normalize the loading of increased steadily up to 72 h, with no further increase
mRNA. seen at 96 h. Similar results were observed in cells
exposed to 1.5 nM PMA. There was no OPN secretion
in media from untreated cells or from cells treated
with RA.
low levels, in HL-60 cells, as reported previously (Bohn-
sack et al., 1995). However, exposure of HL-60 cells to Effect of PMA and retinoic acid treatment on
PMA resulted in an enhancement of b1 mRNA which cell surface expression of b1, b3, av in HL-60 cells
was observed as early as 6 h and maintained up to 72
Having established the mRNA expression pattern forh. In contrast, exposure to RA did not result in b1 OPN-associated receptors, we conducted studies to de-mRNA levels beyond that seen in unstimulated HL-60
termine whether the appearance on the cell surface bycells. HL-60 cells exposed to PMA expressed b3 mRNA, these receptors correlated with their respective mes-with expression noted at 6 h, peaking at 24 h, and
sage. The effect of PMA and RA treatment of HL-60maintained up to 72 h. RA did not promote b3 mRNA cells on expression of cell surface integrins was deter-expression in HL-60 cells.
mined by flow cytometry (Fig. 5). Untreated HL-60 cells
constitutively express b1 on their cell surface, with in-Effect of PMA and retinoic acid treatment creased expression noted at 6 h and increasing up to
on CD44 mRNA in HL-60 cells 72 h in cells exposed to PMA. RA had no effect on b1
cell surface expression beyond that seen with untreatedBasal expression of CD44 mRNA, a cell surface re-
ceptor for OPN (Weber et al., 1996), was noted in un- cells (Fig. 5C). Untreated HL-60 cells did not express
either av or b3, but treatment with PMA caused antreated HL-60 cells (Fig. 3). PMA treatment increased
JCP-650D/ 8934$$650D 02-11-98 11:45:38 wlcpas W Liss: JCP
DIFFERENTIATION AND OPN/OPN RECEPTOR EXPRESSION 233
macrophage pathway results in increased expression
and secretion of OPN and also in increased expression
of CD44 and the integrins av , b3 , and b1 . In contrast,
retinoic acid does not stimulate OPN or receptor ex-
pression in HL-60 cells.
Phorbol ester induction of OPN mRNA expression in
HL-60 cells occurs prior to other PMA-induced changes
in cells associated with differentiation (e.g., adhesion
and induction of NSE activity) (Somerman, et al.,
1995). It was interesting to note that changes in CD44
and integrin mRNA levels and cell surface receptor ex-
pression are later events correlating with the time of
expression of other markers associated with differenti-
ation of HL-60 cells along the monocyte/macrophage
pathway. It is possible that increased secretion of OPN
by HL-60 cells regulates expression of OPN associated
receptors. Substantial evidence exists demonstrating
that the extracellular matrix to which cells are exposed
can control the expression of both mRNA and protein
levels of a variety of integrins (for review see Lin and
Bissell, 1993). OPN, through both alterations in recep-
tor expression and internal signaling activities, may
play a critical role in regulating recruitment of specificFig. 4. OPN secretion in HL-60 cells treated with PMA, as mea-
cell types (e.g. macrophages and osteoclasts) to a heal-sured by ELISA. The concentration of OPN in medium was mea-
sured at specific time points (24, 42, 72, 96 h) after exposure of cells ing site. In support of this, high levels of OPN have
to PMA (0.5 nM). Results are expressed as ng/ml of OPN, using been demonstrated in osteoclasts and in macrophages
recombinant GST-OPN fusion protein as a standard (Argraves et associated with inflammation, wound repair, bone re-al., 1987; Dugaiczyk et al., 1983). This is a representative experi-
modeling, and pathological diseases (Miyazaki et al.,ment; this result was reproducible in two separate experiments.
Error bars represent mean { SD of triplicate samples at each time 1990; Hirota et al., 1993; Giachelli et al., 1995; Murray
point. et al., 1994). In addition, OPN exhibits chemotactic ac-
tivity for several cell types including early T lympho-
cytes (Singh, et al., 1990) and fibroblasts (Weber et al.,
1996).
The question arises as to the role that each of the
increase in both integrins on the cell surface by 24 h, cell surface receptors plays with regard to OPN func-
with a substantial effect noted by 72 h. In contrast, tion. OPN promotes attachment of macrophages and
cells treated with RA for up to 72 h did not express av osteoclasts in vitro (Singh et al., 1990), and evidence
or b3 on their cell surface (Fig. 5A and 5B). has been provided to indicate that avb3 , identified on
both macrophages and osteoclasts, is involved in pro-
Effect of PMA and retinoic acid treatment on moting phagocytic activity (Savill et al., 1990; Fadok
cell surface expression of CD44 in HL-60 cells et al., 1992). The avb3 integrin has also been reported to
participate in OPN-mediated HL-60 cellular adhesionUntreated HL-60 cells constitutively express CD44
stimulated by PMA (Andersson and Johansson, 1996).(Fig. 5D). This level of expression was increased with
In addition to avb3 , other integrins, such as avb1 , haveaddition of PMA by 24 h, and this increase was sus-
been identified on monocytes/macrophages and osteo-tained at 72 h. Conversely, CD44 levels were un-
clasts and thus may also be involved in OPN-mediatedchanged in cells exposed to RA.
cell signaling. The CD44 receptor, which is involved in
homing, attachment, and aggregation of hematopoiticDISCUSSION cells, binds OPN (Weber et al., 1996). This binding ap-
parently mediates both adhesion and chemotaxis (We-Previous work (Somerman et al., 1995), confirmed
here, demonstrated that OPN and av mRNA expression ber et al., 1996). The coordinated expression of OPN
and each of the surface receptors may reflect the differ-is stimulated by PMA. Furthermore, the increased ad-
hesion of HL-60 cells stimulated by PMA has been dem- ent requirements for homing, migration (extravasa-
tion) and finally attachment. For example, it is possibleonstrated to be associated with OPN mRNA expression
and mediated, at least in part, by avb3 (Andersson and that CD44 mediates cell homing and migration, while
avb3 functions via final cell attachment. In summary,Johansson, 1996). It is possible, therefore, that changes
in cell surface receptor expression are important factors results shown here demonstrate that expression of
OPN and its associated receptors are induced and/orcontrolling HL-60 differentiation. This investigation fo-
cused on determining whether OPN-associated cell sur- enhanced during differentiation of HL-60 cells along
the monocyte/macrophage pathway.face receptors, CD44 and the integrin subunits, av , b3 ,
and b1 , are regulated concurrently with OPN during Future studies, directed at blocking the expression
of these molecules during differentiation of cells alongdifferentiation of HL-60 cells along the monocyte/mac-
rophage pathway. The findings indicate that PMA-in- the monocyte/macrophage pathway, will help to clarify
the significance of these molecules in the differentiationduced differentiation of HL-60 cells along the monocyte/
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Fig. 5 Expression of av , b1 , and b3 inte-
grins and CD44 on the cell surface of HL-
60 cells as measured by flow cytometry. HL-
60 cells were cultured in the presence (or
absence/control) of 1.5 nM PMA or 100 nM
RA for 24 h or 72 h. Cells were stained with
either Ig matched mouse immunoglobulin
(light peak) or primary antibodies (dark
peak) against the integrin subunits, human
b3(A), av(B), b1(C), or CD44 (D). FITC-la-
beled secondary antibody was applied, and
cells were analyzed by flow cytometry. The
y axis represents cell number, and the x axis
represents log fluorescence intensity. Re-
sults were from one representative experi-
ment; the pattern shown here was repro-
duced in four separate experiments.
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Fig. 5. (Continued. )
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OPN expression by a targeted ribozyme. Clin. Exp. Metastasis,process. Delineation of the role that each of these recep-
13:453–462.tors plays in relation to OPN during differentiation will Gardner, H.A.R., Berse, B., and Senger, D.R. (1994) Specific reductionbe useful in defining the function of OPN in that pro- in osteopontin synthesis by antisense RNA inhibits the tumorigen-
cess. icity of transformed Rat1 fibroblasts. Oncogene, 9:2321–2326.
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